Cases & Deals

Inveni purchases shares in Priaxon

Clients Inveni Fund I Oy

Jones Day represented Inveni Fund I Oy in connection with its purchase of Common Stock in a private placement by Priaxon AG, a research company focusing on medicinal chemistry and drug discovery for small molecule therapeutics.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.